Correlation Between Bank of America and Monopar Therapeutics

Can any of the company-specific risk be diversified away by investing in both Bank of America and Monopar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bank of America and Monopar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bank of America and Monopar Therapeutics, you can compare the effects of market volatilities on Bank of America and Monopar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bank of America with a short position of Monopar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bank of America and Monopar Therapeutics.

Diversification Opportunities for Bank of America and Monopar Therapeutics

0.81

Correlation Coefficient

Bank of America  Monopar Therapeutics

Very poor diversification

The 3 months correlation between Bank and Monopar is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Bank of America and Monopar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Monopar Therapeutics and Bank of America is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bank of America are associated (or correlated) with Monopar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Monopar Therapeutics has no effect on the direction of Bank of America i.e., Bank of America and Monopar Therapeutics go up and down completely randomly.

Pair Corralation between Bank of America and Monopar Therapeutics

Considering the 90-day investment horizon Bank of America is expected to generate 38.81 times less return on investment than Monopar Therapeutics. But when comparing it to its historical volatility, Bank of America is 47.58 times less risky than Monopar Therapeutics. It trades about 0.17 of its potential returns per unit of risk. Monopar Therapeutics is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  239.00  in Monopar Therapeutics on August 30, 2024 and sell it today you would earn a total of  1,831  from holding Monopar Therapeutics or generate 766.11% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Bank of America  vs.  Monopar Therapeutics

Bank of America

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Bank of America are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, Bank of America exhibited solid returns over the last few months and may actually be approaching a breakup point.

Monopar Therapeutics

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Monopar Therapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Monopar Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Bank of America and Monopar Therapeutics

The main advantage of trading using opposite Bank of America and Monopar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bank of America position performs unexpectedly, Monopar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monopar Therapeutics will offset losses from the drop in Monopar Therapeutics' long position.

The idea behind Bank of America and Monopar Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.